Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-002921

CEO and CFO bought 5,500 shares at $8.73 ($48,015)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-04-04 Purchase +5,500 $8.73 $48,015 5,558,002 D: show line 1 in the form
Open-market purchases · 5,500 sh · avg $8.73 · $48,015
Loading xslF345X05/ownership.xml…